CellBion Statistics
Total Valuation
CellBion has a market cap or net worth of KRW 349.31 billion. The enterprise value is 323.58 billion.
Market Cap | 349.31B |
Enterprise Value | 323.58B |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
CellBion has 12.82 million shares outstanding.
Current Share Class | 12.82M |
Shares Outstanding | 12.82M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 36.45% |
Owned by Institutions (%) | 3.59% |
Float | 8.15M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 132.89 |
PB Ratio | 13.24 |
P/TBV Ratio | 13.56 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -43.55 |
EV / Sales | 123.10 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -50.63 |
Financial Position
The company has a current ratio of 28.47, with a Debt / Equity ratio of 0.10.
Current Ratio | 28.47 |
Quick Ratio | 27.82 |
Debt / Equity | 0.10 |
Debt / EBITDA | n/a |
Debt / FCF | -0.40 |
Interest Coverage | -72.31 |
Financial Efficiency
Return on equity (ROE) is -48.16% and return on invested capital (ROIC) is -26.56%.
Return on Equity (ROE) | -48.16% |
Return on Assets (ROA) | -22.90% |
Return on Invested Capital (ROIC) | -26.56% |
Return on Capital Employed (ROCE) | -24.81% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.13 |
Inventory Turnover | 3.16 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | 24,816.40 |
200-Day Moving Average | 18,196.35 |
Relative Strength Index (RSI) | 53.97 |
Average Volume (20 Days) | 227,104 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CellBion had revenue of KRW 2.63 billion and -7.43 billion in losses.
Revenue | 2.63B |
Gross Profit | 1.02B |
Operating Income | -7.65B |
Pretax Income | -7.43B |
Net Income | -7.43B |
EBITDA | -7.00B |
EBIT | -7.65B |
Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 28.29 billion in cash and 2.55 billion in debt, giving a net cash position of 25.73 billion or 2,007.55 per share.
Cash & Cash Equivalents | 28.29B |
Total Debt | 2.55B |
Net Cash | 25.73B |
Net Cash Per Share | 2,007.55 |
Equity (Book Value) | 26.39B |
Book Value Per Share | n/a |
Working Capital | 28.53B |
Cash Flow
In the last 12 months, operating cash flow was -6.15 billion and capital expenditures -238.52 million, giving a free cash flow of -6.39 billion.
Operating Cash Flow | -6.15B |
Capital Expenditures | -238.52M |
Free Cash Flow | -6.39B |
FCF Per Share | -498.56 |
Margins
Gross margin is 38.79%, with operating and profit margins of -290.98% and -282.69%.
Gross Margin | 38.79% |
Operating Margin | -290.98% |
Pretax Margin | -282.69% |
Profit Margin | -282.69% |
EBITDA Margin | -266.20% |
EBIT Margin | -290.98% |
FCF Margin | n/a |
Dividends & Yields
CellBion does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -2.13% |
FCF Yield | -1.83% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
CellBion has an Altman Z-Score of 21.29 and a Piotroski F-Score of 3.
Altman Z-Score | 21.29 |
Piotroski F-Score | 3 |